Pediatric Oncology
The Strategic Case for Investing in Pediatric Oncology, Beyond Altruism
Emilee Kudla
Pharma's Almanac
PAO-08-25-NI-04Aug 05, 2025
Pediatric Oncology
The "Therapeutic Winter" and Why Urgent Innovation in Pediatric Oncology Is Being Left Behind
Emilee Kudla
Pharma's Almanac
PAO-08-25-NI-03Aug 05, 2025
R&D Funding
Cutting Public R&D Would Slash U.S. GDP, Innovation, and Industry Growth, New Report Warns
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-25-NI-15Apr 30, 2025
Financial Literacy
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Emilee Kudla
Pharma's Almanac
PAO-03-25-NI-01Mar 14, 2025
xRNA
Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-02-25-CL-11Feb 13, 2025
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
Nice Insight
PAO-06-24-NI-01Jun 11, 2024
Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01Apr 02, 2024
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12Jun 24, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02Jun 24, 2022
Private Equity
Supporting Growth for Middle-Market Companies
Jeffrey Marlough
Castleford Capital
PAO-02-22-R250-22Feb 27, 2022
Cell and Gene Therapy
Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market
Philip Gialenios
Kineticos Life Sciences
PAO-11-21-CL-15Dec 01, 2021
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
Mike Nicholson, Ph.D.
Inceptor Bio
PAO-10-21-CL-14Oct 22, 2021
Medical Devices
Investing with a Focus on Medical Devices and Digital Health
Cecile Real
Medevice
PAP-Q3-20-CL-023Sep 29, 2020